GlassScriptPhysician profile
Kendra M Bloomfield
NPI 1609118900
$1,027.10
in general payments reported to CMS, 2019-2025
12 companies · $96.64 in 2025
The $96.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $17.12 · 2022: $95.35 · 2023: $144 · 2024: $488 · 2025: $96.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $436 · Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $435.50 |
| Food and Beverage | $293.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $504.91 | 2019-2024 | Da Vinci Surgical System |
| Abbvie INC. | $95.38 | 2019 | |
| Hologic Sales and Service, LLC | $95.35 | 2022 | |
| Si-Bone, INC. | $76.01 | 2023 | |
| Pfizer INC. | $57.41 | 2024-2025 | |
| Biogen, INC. | $53.97 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $50.77 | 2023 | Injectafer |
| Clovis Oncology, INC. | $21.93 | 2019 | |
| Coopersurgical, INC. | $19.59 | 2024 | Paragard T 380a |
| Molnlycke Health Care US, LLC | $18.00 | 2025 | Avance, Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Bayer Healthcare Pharmaceuticals INC. | $17.12 | 2020 | |
| Merck Sharp & Dohme LLC | $16.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Bloomfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.